Decoy Therapeutics Inc (DCOY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,936 | -5,053 | -2,426 | -1,522 | -1,670 |
| Depreciation Amortization | 127 | 123 | 119 | 115 | 17 |
| Accounts receivable | 1 | 1 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -519 | -593 | 1,009 | 590 | -286 |
| Other Working Capital | -4,212 | -3,462 | -1,136 | -497 | 5,799 |
| Other Operating Activity | -41 | 42 | -967 | -554 | 316 |
| Operating Cash Flow | $-11,580 | $-8,944 | $-3,402 | $-1,869 | $4,177 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | 204 | 204 | N/A | N/A | N/A |
| Other Investing Activity | 5,404 | 5,404 | 0 | 0 | 0 |
| Investing Cash Flow | $5,608 | $5,608 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,131 | 1,508 | 1,508 | 1,508 | 2,050 |
| Dividend Paid | -134 | -134 | -100 | N/A | N/A |
| Other Financing Activity | -418 | -171 | 0 | 0 | -615 |
| Financing Cash Flow | $3,579 | $1,204 | $1,408 | $1,508 | $1,435 |
| Beginning Cash Position | 6,132 | 6,132 | 6,132 | 6,132 | 519 |
| End Cash Position | 3,739 | 4,000 | 4,139 | 5,771 | 6,132 |
| Net Cash Flow | $-2,393 | $-2,132 | $-1,993 | $-361 | $5,612 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,580 | -8,944 | -3,402 | -1,869 | 4,177 |
| Free Cash Flow | -11,580 | -8,944 | -3,402 | -1,869 | 4,177 |